Amgen Enbrel Rhode Island Facility To Get FDA Inspection In Early November

FDA will inspect Amgen's Enbrel Rhode Island manufacturing plant in early November, Amgen said during its third quarter earnings call on Oct. 23

More from Archive

More from Pink Sheet